Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1150.00 27.05 (2.41%) | NSE 1154.80 31.00 (2.76%) | Trade | Add

BSE Live

Nov 10, 16:01

1150.00 27.05 (2.41%)

Volume

AVERAGE VOLUME

5-Day

78,582

10-Day

67,325

30-Day

40,807

13,123

Prev. Close

1122.95
Open Price

1127.65

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 10, 15:56

1154.80 31.00 (2.76%)

Volume

AVERAGE VOLUME

5-Day

1,881,055

10-Day

1,498,077

30-Day

1,339,009

1,384,229

Prev. Close

1123.80
Open Price

1126.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1154.80 (1335)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Aurobindo Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	31,378.13	28,704.50	24,617.13	23,366.55	24,557.94
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	31,378.13	28,704.50	24,617.13	23,366.55	24,557.94
Total Operating Revenues	31,723.73	29,001.87	24,855.38	23,455.49	24,774.62
Other Income	621.85	557.38	290.59	320.35	380.85
Total Revenue	32,345.58	29,559.25	25,145.97	23,775.84	25,155.47
EXPENSES
Cost Of Materials Consumed	10,736.76	10,776.14	9,652.51	7,371.83	8,317.26
Purchase Of Stock-In Trade	2,887.11	2,772.93	2,050.43	1,951.77	2,315.42
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-597.63	-946.17	-409.68	816.68	-730.21
Employee Benefit Expenses	4,475.62	3,922.94	3,522.25	3,450.92	3,535.02
Finance Costs	457.24	289.71	140.48	48.64	74.49
Depreciation And Amortisation Expenses	1,649.42	1,521.66	1,244.58	1,126.52	1,055.39
Other Expenses	7,639.08	6,633.03	6,321.23	5,477.52	6,003.73
Total Expenses	27,247.60	24,970.24	22,521.80	20,243.88	20,571.10
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5,097.98	4,589.01	2,624.17	3,531.96	4,584.37
Exceptional Items	0.00	-191.86	0.00	-127.97	2,814.58
Profit/Loss Before Tax	5,097.98	4,397.15	2,624.17	3,403.99	7,398.95
Tax Expenses-Continued Operations
Current Tax	1,699.98	1,777.54	1,071.48	662.82	2,321.82
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-117.26	-566.52	-386.63	62.81	-312.05
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	1,582.72	1,211.02	684.85	725.63	2,009.77
Profit/Loss After Tax And Before ExtraOrdinary Items	3,515.26	3,186.13	1,939.32	2,678.36	5,389.18
Profit/Loss From Continuing Operations	3,515.26	3,186.13	1,939.32	2,678.36	5,389.18
Profit/Loss For The Period	3,515.26	3,186.13	1,939.32	2,678.36	5,389.18
Minority Interest	2.31	4.00	-0.15	1.04	1.02
Consolidated Profit/Loss After MI And Associates	3,485.88	3,172.97	1,927.50	2,648.15	5,334.84
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	60.00	54.00	33.00	45.00	91.00
Diluted EPS (Rs.)	60.00	54.00	33.00	45.00	91.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	439.45	263.67	234.38
Tax On Dividend	0.00	0.00	0.00	0.00	0.00